Tmunity Therapeutics has a total of 19 patents globally, out of which no patents have been granted. Of these 19 patents, more than 84% patents are active. United States of America is where Tmunity Therapeutics has filed the maximum number of patents, followed by Canada and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Tmunity Therapeutics.
Tmunity Therapeutics was founded in the year 2015. The Company operates as a bio-therapeutics company. The Company engages in developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indication.
Do read about some of the most popular patents of Tmunity Therapeutics which have been covered by us in this article and also you can find Tmunity Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tmunity Therapeutics patent portfolio.
How many patents does Tmunity Therapeutics have?
Tmunity Therapeutics has a total of 19 patents globally. These patents belong to 5 unique patent families. Out of 19 patents, 16 patents are active.
How Many Patents did Tmunity Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Tmunity Therapeutics Applications Filed | Tmunity Therapeutics Patents Granted |
| 2023 | 2 | – |
| 2022 | 4 | – |
| 2021 | 11 | – |
| 2020 | 2 | – |
How many Tmunity Therapeutics patents are Alive/Dead?
How Many Patents did Tmunity Therapeutics File in Different Countries?
Countries in which Tmunity Therapeutics Filed Patents
| Country | Patents |
| United States of America | 3 |
| Canada | 2 |
| Japan | 2 |
| Australia | 2 |
| Europe | 2 |
| Hong Kong (S.A.R.) | 2 |
| Taiwan | 1 |
Where are Research Centres of Tmunity Therapeutics Patents Located?
The Research Centre for all the Tmunity Therapeutics patents is the United States of America.
What Percentage of Tmunity Therapeutics US Patent Applications were Granted?
Tmunity Therapeutics (Excluding its subsidiaries) has filed 1 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Tmunity Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Tmunity Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Foley & Lardner Llp | 1 | 0% |
List of Tmunity Therapeutics Patents
| Tmunity Therapeutics Patents | Title |
| US20230304037A1 | Methods For Producing Clinical-Grade Lentiviral Vector |
| US20230190809A1 | Alternative Generation Of Allogeneic Human T Cells |
| US20210060070A1 | Adoptive Cell Therapy And Methods Of Dosing Thereof |
| EP4204574A1 | Vector-Free Process For Manufacture Of Engineered Immune Cells |
| EP4196596A1 | Methods For Producing Clinical-Grade Lentiviral Vector |
| HK40094125A | Vector-Free Process For Manufacture Of Engineered Immune Cells |
| HK40094128A | Methods For Producing Clinical-Grade Lentiviral Vector |
| JP2023540041A | Vector-Free Process To Produce Artificial Immune Cells |
| JP2023537979A | How To Produce Clinical Grade Lentiviral Vectors |
| AU2021332334A1 | Vector-Free Process For Manufacture Of Engineered Immune Cells |
| AU2021324776A1 | Methods For Producing Clinical-Grade Lentiviral Vector |
| WO2023039041A1 | Alternative Generation Of Allogeneic Human T Cells |
| WO2023009412A1 | Dnvsig3 And Dnvsig8 Receptors And Methods Of Using The Same |
| CA3188371A1 | Vector-Free Process For Manufacture Of Engineered Immune Cells |
| CA3188923A1 | Methods For Producing Clinical-Grade Lentiviral Vector |
| TW202321436A | Alternative Generation Of Allogeneic Human T Cells |
| WO2022047003A1 | Vector-Free Process For Manufacture Of Engineered Immune Cells |
| WO2022036048A1 | Methods For Producing Clinical-Grade Lentiviral Vector |
| WO2021046205A1 | Adoptive Cell Therapy And Methods Of Dosing Thereof |
What are Tmunity Therapeutics key innovation segments?
What Technologies are Covered by Tmunity Therapeutics?
The chart below distributes patents filed by Tmunity Therapeutics